Testing effectiveness (Phase 2)Study completedNCT00496873What this trial is testingEvaluation of the Safety and Efficacy of Nipent, Cytoxan, and RituxanWho this might be right forLymphoma M.D. Anderson Cancer Center 100
Early research (Phase 1)UnknownNCT00457860What this trial is testingSafety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance DiseaseWho this might be right forLeukemia Cambridge Antibody Technology 50
Testing effectiveness (Phase 2)Study completedNCT00535873What this trial is testingLenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and OlderWho this might be right forLeukemiaCLLChronic Lymphocytic Leukemia+1 more M.D. Anderson Cancer Center 61
Early research (Phase 1)Active Not RecruitingNCT02787369What this trial is testingACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLLWho this might be right forRecurrent Chronic Lymphoid Leukemia Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT00006225What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic CancerWho this might be right forBreast CancerLeukemiaLymphoma+2 more Northwestern University
Early research (Phase 1)Study completedNCT04018248What this trial is testingBR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)Who this might be right forDiffuse Large B Cell LymphomaFollicular LymphomaChronic Lymphocytic Leukemia+5 more Boryung Pharmaceutical Co., Ltd 26
Testing effectiveness (Phase 2)Study completedNCT00104858What this trial is testingFludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more Fred Hutchinson Cancer Center 66
Large-scale testing (Phase 3)Study completedNCT03480360What this trial is testingHaploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' ExpressionWho this might be right forAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid Leukemia+6 more Dartmouth-Hitchcock Medical Center 21
Early research (Phase 1)Study completedNCT01955668What this trial is testingAZD6738 First Time in Patient Multiple Ascending Dose StudyWho this might be right for11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),Prolymphocytic Leukaemia (PLL)B Cell Lymphomas AstraZeneca 2
Testing effectiveness (Phase 2)Study completedNCT01413568What this trial is testingSafety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more Polyphor Ltd. 38
Not applicableStudy completedNCT04290923What this trial is testingDetermination of Blood Tumor CellsWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellAbnormalities Cell Epithelial University of Zurich 71
Testing effectiveness (Phase 2)Ended earlyNCT00265915What this trial is testingRituximab and GM-CSF in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Active Not RecruitingNCT04072458What this trial is testingA Clinical Trial of BP1002 in Patients With Advanced Lymphoid MalignanciesWho this might be right forMantle Cell LymphomaPeripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL)+7 more Bio-Path Holdings, Inc. 30
Early research (Phase 1)Study completedNCT02280525What this trial is testingCord Blood Natural Killer (NK) Cells in Leukemia/LymphomaWho this might be right forLeukemia M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT03128359What this trial is testingHigh Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell TransplantWho this might be right forAcute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more City of Hope Medical Center 38
Testing effectiveness (Phase 2)Study completedNCT01392079What this trial is testingSubcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to FludarabineWho this might be right forChronic Lymphocytic Leukemia University of Ulm 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06367374What this trial is testingMRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Institute of Hematology & Blood Diseases Hospital, China 66
Testing effectiveness (Phase 2)Study completedNCT03204188What this trial is testingIbrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forB-Cell Chronic Lymphocytic LeukemiaB-Lymphocytic Leukemia, ChronicChronic Lymphocytic Leukemia+6 more National Heart, Lung, and Blood Institute (NHLBI) 15
Testing effectiveness (Phase 2)Ended earlyNCT01013961What this trial is testingRituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia ECOG-ACRIN Cancer Research Group 31
Testing effectiveness (Phase 2)Study completedNCT00980395What this trial is testingBortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent LymphomaWho this might be right forLymphomaMantle Cell LymphomaIndolent Lymphoma+1 more University of Arizona 24